Trial intelligence / Profile preview

Fluoride Dose Response of MFP Dentifrice In Situ

NCT04763044Phase 4Completed

Sponsor
Procter & Gamble
Start
Mar 2021
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sodium monofluorophosphate in dental caries, sponsored by Procter & Gamble. Started Mar 2021; status: completed.

02

Drugs

sodium monofluorophosphate
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT04763044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04763044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call